Wed, Oct 14, 2015
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Prologue Capital names Devin Graham as chief risk officer

Thursday, November 19, 2009
Opalesque Industry Updates - Prologue Capital, LLP, an alternative investment firm that manages a discretionary fixed income strategy, today announced that Devin Graham, 36, has joined the firm as Chief Risk Officer. He is based at the company’s headquarters in London and reports to David Lofthouse, Prologue’s CEO.

Mr. Graham will oversee market, liquidity and counterparty risk, policy development and compliance for Prologue’s funds.

“We are delighted to have Devin on board and his expertise will add a vital new layer to our investment processes,” said Mr. Lofthouse. “Risk management is an integral part of our philosophy and this role will expand as we continue to grow.”

"The prologue team has demonstrated an excellent ability to manage their business and capital during periods of extreme stress, most notably 2008. I look forward to building upon and enhancing their proven process,” said Graham.

Mr. Graham has more than 13 years of experience in trading, and risk and business management. He was most recently Global Head of FX Prime Brokerage for UBS where he was responsible for risk management, IT Provision, operations and marketing. Prior to that, he was an FX derivatives trader and risk management adviser at Swiss Bank O’Connor. Throughout his career he has been responsible for establishing and managing numerous new business lines, including online structured product trading and client risk management and position reporting. He received his Bachelor of Science degree in Biomechanical Engineering from the Massachusetts Institute of Technology (MIT). Corpoate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Manager Profile - Pimco alternative funds flourish as 30-year bond rally fades[more]

    From Inside Pacific Investment Management Co., the bond behemoth that lost two chief investment officers last year and saw almost $500 billion of client money leave, a hidden profit engine is easing some of the pain. For more than a decade, Newport Beach, California-based Pimco has qu

  2. Niche Investing - Art investment funds: Attracting institutional and other new investors[more]

    From The Deloitte/ArtTactic Art and Finance Report 2014 (the "Art and Finance Report") noted that the "global art investment fund market was estimated to be worth at least $1.26 billion in the first half of 2014." This seems almost inconsequential when juxtaposed with the $54 billion of

  3. Other Voices: Why fund boards must develop a response to cyber security and financial crime threats[more]

    This article was written by Carne, an international specialist in the provision of independent governance services and European management company solutions to the global asset management industry. A recent SEC action has highlighted how concerned regulators have become about data intru

  4. Hedge funds relatively resilient in Q3[more]

    Komfie Manalo, Opalesque Asia: Hedge funds fell in the third quarter as market conditions remain challenging, but still outperformed the S&P 500. The Lyxor Hedge Fund index was down 3.6% during Q3 while the S&P 500 fell 8.2%. According to Lyxor, "hedge funds were quite resilient in Q3. Falling en

  5. Hedge funds start Q4 on strong footing reversing the previous market downturn[more]

    Komfie Manalo, Opalesque Asia: Hedge funds started the fourth quarter on a strong footing, reversing the previous market downturn with the Lyxor Hedge Fund Index up 1.1% as of end Oct. 6 (-0.7% YTD). Event-driven outperformed, up 2.2% (-4.2% YTD), and CTAs underperformed (- 1.9%), extrapolatin